Obesity and diabetes: Newer concepts in imaging

Diabetes Technology and Therapeutics

Volumn 15, Issue 5, 2013, Pages 351-361

  Garg, Kavita ^a   Chang, Samuel ^a   Scherzinger, Ann ^a  

^a UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; INSULIN;

ABDOMINAL OBESITY; BARIATRIC SURGERY; BODY COMPOSITION; BODY FAT; BONE SCINTISCANNING; BREAST CANCER; BROWN ADIPOSE TISSUE; CARDIOVASCULAR DISEASE; CAROTID ARTERIOGRAPHY; CLINICAL DECISION MAKING; COLON CANCER; COLONOSCOPY; COMPUTER ASSISTED TOMOGRAPHY; COST EFFECTIVENESS ANALYSIS; DIABETES MELLITUS; DISEASE ASSOCIATION; DISEASE PREDISPOSITION; ECHOCARDIOGRAPHY; ELASTOGRAPHY; HEART MUSCLE; HUMAN; INSULIN RESISTANCE; IONIZING RADIATION; LIVER BIOPSY; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; METABOLIC SYNDROME X; NEUROPATHY; NON INSULIN DEPENDENT DIABETES MELLITUS; NONALCOHOLIC FATTY LIVER; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; OBESITY; OUTCOME ASSESSMENT; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; PROGNOSIS; PROSTATE CANCER; REVIEW; RISK ASSESSMENT; UTERINE CERVIX CANCER;

BARIATRIC SURGERY; BODY MASS INDEX; CARDIOVASCULAR DISEASES; DIABETES MELLITUS, TYPE 2; DISEASE PROGRESSION; ELASTICITY IMAGING TECHNIQUES; FATTY LIVER; FEMALE; HUMANS; MAGNETIC RESONANCE SPECTROSCOPY; MALE; NEOPLASMS; OBESITY; PREDICTIVE VALUE OF TESTS; RISK FACTORS; TOMOGRAPHY, X-RAY COMPUTED;

EID: 84877662223     PISSN: 15209156     EISSN: 15578593     Source Type: Journal    
DOI: 10.1089/dia.2013.0039     Document Type: Review

References (65)

1. Ogden CL, Carroll MD, Kit BK, Flegal KM: Prevalence of Obesity in the United States, 2009-2010. NCHS Data Brief, No. 82. Hyattsville, MD: National Center for Health Statistics, 2012.
2. Total National Health Expenditures: Centers for Medicare & Medicaid Services, Office of the Actuary: Data from the National Statistics Group, October 2010.
3. Lopez AD, Mathers CD, Ezzati M, Jamison DT, Murray CJ: Global and regional burden of disease and risk factors, 2001: Systematic analysis of population health data. Lancet 2006;367:1747-1757.
4. International Diabetes Federation: Diabetes Atlas, 5th ed. 2011. www.idf.org/sites/default/files/NAC-5E-Update- Country.pdf (accessed January 2013
5. Garg SK, Moser E: How basal insulin analogs have changed diabetes care. Diabetes Technol Ther 2011;13(SUPPL.):S-1-S-4.
6. Garg SK, DiDomenico D, Switzer S: Ways to reduce cardiovascular disease in diabetes. Diabetes Technol Ther 2012;14(SUPPL. 1):S-1-S-2.
7. Guh DP, Zhang W, Bansback N, Amarsi Z, Birmingham CL, Anis AH: The incidence of co-morbidities related to obesity and overweight: A systematic review and meta-analysis. BMC Public Health 2009;9:88.
8. Seidell JC, Bjorntorp P, Sjostrom L, Sannerstedt R, Krotkiewski M, Kvist H: Regional distribution of muscle and fat mass in men - new insight into the risk of abdominal obesity using computed tomography. Int J Obes 1989;13:289-303.
9. Sidney S, Lewis CE, Hill JO, Quesenberry CP Jr, Stamm ER, Scherzinger A, Tolan K, Ettinger B: Association of total and central adiposity measures with fasting insulin in a biracial population of young adults with normal glucose tolerance: The CARDIA study. Obes Res 1999;7:265-272.
10. Rossi AP, Fantin F, Zamboni GA, Mazzali G, Rinaldi CA, Giglio MD, Di Francesco V, Barillari M, Mucelli RP, Zamboni M: Predictors of ectopic fat accumulation in liver and pancreas in obese men and women. Obesity (Silver Spring) 2011;19:1747-1754.
11. Rosito GA, Massaro JM, Hoffmann U, Ruberg FL, Mahabadi AA, Vasan RS, O'Donnell CJ, Fox CS: Pericardial fat, visceral abdominal fat, cardiovascular disease risk factors, and vascular calcification in a communitybased sample: The Framingham Heart Study. Circulation 2008;117:605-613.
12. Donohoe CL, Doyle SL, Reynolds JV: Visceral adiposity, insulin resistance and cancer risk. Diabetol Metab Syndr 2011;3:12.
13. American College of Radiology: ACR Appropriateness Criteria. Radiation Dose Assessment Introduction. www.acr .org (accessed January 16, 2013
14. University of Colorado Department of Radiology: Radiation Dose Smart Card. 2012. www.ucdenver.edu/academics/ colleges/medicalschool/departments/ Radiology/Pages/ Radiology.aspx (accessed January 21, 2013
15. Saini S, Seltzer SE, Bramson RT, Levine LA, Kelley P, Jordan PF Chiango BF, Thrall JH: Technical cost of radiologic examinations: Analysis across imaging modalities. Radiology 2000;216:269-272.
16. Borkan GA, Gerzof SG, Robbins AH, Hults DE, Silbert CK, Silbert JE: Assessment of abdominal fat content by computed tomography. Am J Clin Nutr 1982;36:172-177.
17. Amati F, Pennant M, Azuma K, Dubé JJ, Toledo FGS, Rossi AP, Kelley DE, Goodpaster BH: Lower thigh subcutaneous and higher visceral abdominal adipose tissue content both contribute to insulin resistance. Obesity (Silver Spring) 2012;20:1115-1117.
18. Limanond P, Raman SS, Lassman C, Sayer J, Ghobrial RM, Busuttil RW, Saab S, Lu DS: Macrovesicular hepatic steatosis in living related liver donors: Correlation between CT and histologic findings. Radiology 2004;230:276-280.
19. Seidell, JC, Bakker CJ, van der Kooy K. Imaging techniques for measuring adipose-tissue distribution - a comparison between computed tomography and 1.5-T magnetic resonance. Am J Clin Nutr 1990;51:953-957.
20. Klopfenstein BJ, Kim MS, Krisky CM, Szumowski J, Rooney WD, Purnell JQ: Comparison of 3 T MRI and CT for the measurement of visceral and subcutaneous adipose tissue in humans. Br J Radiol 2012;85:e826-e830.
21. Dixon WT: Simple proton spectroscopic imaging. Radiology 1984;153:189-194.
22. Ma J, Singh SK, Kumar AJ, Leeds NE, Broemeling LD: Method for efficient fast spin echo Dixon imaging. Magn Reson Med 2002;48:1021-1027.
23. Liu C-Y, McKenzie CA, Yu H, Brittain JH, Reeder SB: Fat quantification with IDEAL gradient echo imaging: Correction of bias from T1 and noise. Magn Reson Med 2007; 58:354-364.
24. Reeder SB, Cruite I, Hamilton G, Sirlin CB: Quantitative assessment of liver fat with magnetic resonance imaging and spectroscopy. J Magn Reson Imaging 2011;34: 729-749.
25. Szczepaniak LS, Babcock EE, Schick F, Dobbins RL, Garg A, Burns DK, McGarry JD, Stein DT: Measurement of intracellular triglyceride stores by 1H spectroscopy: Validation in vivo. Am J Physiol 1999;276:E977-E989.
26. Lingvay I, Esser V, Legendre JL, Price AL, Wertz KM, Adams-Huet B, Zhang S, Unger RH, Szczepaniak LS: Noninvasive quantification of pancreatic fat in humans. J Clin Endocrinol Metab 2009;94:4070-4076.
27. Kang B-K, Yu ES, Lee SS, Lee Y, Kim N, Sirlin CB, Cho EY, Yeom SK, Byun JH, Park SH, Lee M-G: Hepatic fat quantification: A prospective comparison of magnetic resonance spectroscopy and analysis methods for chemical-shift gradient echo magnetic resonance imaging with histologic assessment as the reference standard. Invest Radiol 2012; 47:368-375.
28. Bohte AE, van Werven JR, Bipat S, Stoker J: The diagnostic accuracy of US, CT, MRI and 1H-MRS for the evaluation of hepatic steatosis compared with liver biopsy: A meta-analysis. Eur Radiol 2011;21:87-97.
29. Maligie M, Crume T, Scherzinger A, Stamm E, Dabelea D: Adiposity, fat patterning, and the metabolic syndrome among diverse youth: The EPOCH study. J Pediatr 2012; 161:875-880.
30. Pickhardt PJ, Lee Y, O'Connor SD, Mun? oz del Rio A: Visceral adiposity and hepatic steatosis at abdominal CT: Association with the metabolic syndrome AJR 2012;198: 1100-1107.
31. Dulloo AG, Jacquet J, Solinas G, Montani J-P, Schutz Y: Body composition phenotypes in pathways to obesity and the metabolic syndrome. Int J Obes (Lond) 2010;34(SUPPL. 2):S4- S17.
32. Maskarinec G, Grandinetti A, Matsuura G, Sharma S, Mau M, Henderson BE, Kolonel LN: Diabetes prevalence and body mass index differ by ethnicity: The Multiethnic Cohort. Ethn Dis 2009;19:49-55.
33. Nazare J, Smith JD, Borel A, Haffner SM, Balkau B, Ross R, Massien C, Almeras N, Despres JP: Ethnic influences on the relations between abdominal subcutaneous and visceral adiposity, liver fat, and cardiometabolic risk profile: The International Study of Prediction of Intra-Abdominal Adiposity and Its Relationship with Cardiometabolic Risk/Intra- Abdominal Adiposity. Am J Clin Nutr 2012;96:714-726.
34. Cypess AM, Lehman S, Williams G, Tal I, Rodman D, Goldfine AB, Kuo FC, Palmer EL, Tseng YH, Doria A, Kolodny GM, Kahn CR: Identification and importance of brown adipose tissue in adult humans. N Engl J Med 2009;360:1509-1517.
35. Saito M, Okamatsu-Ogura Y, Matsushita M, Watanabe K, Yoneshiro T, Nio-Kobayashi J, Iwanaga T, Miyagawa M, Kameya T, Nakada K, Kawai Y, Tsujisaki M: High incidence of metabolically active brown adipose tissue in healthy adult humans: Effects of cold exposure and adiposity. Diabetes 2009;58:1526-1531.
36. Ouellet V, Labbe SM, Blondin DP, Phoenix S, Guerin B, Haman F, Turcotte EE, Richard D, Carpentier AC: Brown adipose tissue oxidative metabolism contributes to energy expenditure during acute cold exposure in humans. J Clin Invest 2012;122:545-552.
37. Ouellet V, Routhier-Labadie A, Bellemare W, Lakhal-Chaieb L, Turcotte E, Carpentier AC, Richard D: Outdoor temperature, age, sex, body mass index, and diabetic status determine the prevalence, mass, and glucose-uptake activity of 18F-FDG-detected BAT in humans. J Clin Endocrinol Metab 2011;96:192-199.
38. Rothwell NJ, Stock MJ: Luxuskonsumption, diet-induced thermogenesis and brown fat: The case in favour. Clin Sci (Lond) 1983;64:19-23.
39. Feldmann HM, Golozoubova V, Cannon B, Nedergaard J: UCP1 ablation induces obesity and abolishes diet-induced thermogenesis in mice exempt from thermal stress by living at thermoneutrality. Cell Metab 2009;9:203-209.
40. Khalili K, Lan FP, Hanbidge AE: Hepatic subcapsular steatosis in response to intraperitoneal insulin delivery: CT findings and prevalence. AJR Am J Roentgenol 2003;180: 1601-1604.
41. Schwenzer NF, Springer F, Schraml C, Stefan N, Machann J, Schick F: Noninvasive assessment and quantification of liver steatosis by ultrasound, computed tomography and magnetic resonance. J Hepatol 2009;51:433-445.
42. Friedrich-Rust M, Ong MF, Martens S Sarazzin C, Bojunga J, Zeuzem S, Hermmann E: Performance of transient elastography for the staging of liver fibrosis: A meta-analysis. Gastroenterology 2008;134:960-974.
43. Yoneda M, Suzuki K, Kato S, Fujita K, Nozaki Y, Hosono K, Saito S, Nlakajima A: Nonalcoholic fatty liver disease: USbased acoustic radiation force impulse elastography. Radiology 2010;256:640-647.
44. Chen J, Talwalkar JA, Yin M, Glaser KJ, Sanderson SO, Ehman RL: Early detection of nonalcoholic steatohepatitis in patients with nonalcoholic fatty liver disease by using MR elastography. Radiology 2011;259:749-756.
45. Park SH, Kim PN, Kim KW, Lee SW, Yoon SE, Park SW, Ha HK, Lee MG, Hwang S, Lee SG, Yu ES, Cho EY: Macrovesicular hepatic steatosis in living liver donors: Use of CT for quantitative and qualitative assessment. Radiology 2006; 239:105-112.
46. Joe E, Lee JM, Kim KW, Lee KB, Kim SJ, Baek JH, Shin C Suh KS, Yi NJ, Han JK, Choi BI: Quantification of hepatic macrosteatosis in living, related liver donors using T1-independent, T2.-corrected chemical shift MRI. J Magn Reson Imaging 2012;36:1124-1130.
47. Cowin GJ, Jonsson JR, Bauer JD, Ash S, Ali A, Osland EJ, Purdie DM, Clouston AD, Powell EE, Galloway GJ: Magnetic resonance imaging and spectroscopy for monitoring liver steatosis. J Magn Reson Imaging 2008;28:937-945.
48. Chandler RC, Srinivas G, Chintapalli KN, Schwesinger WH, Prasad SR: Imaging in bariatric surgery: A guide to postsurgical anatomy and common complications. AJR Am J Roentgenol 2008;190:122-135.
49. Wu TM, Yang P, Huang YL, Chen JS, Chuo CC, Yeh C, Chang RS: Coronary arterial calcification on low-dose ungated MDCT for lung cancer screening: Concordance study with dedicated cardiac CT. AJR Am J Roentgenol 2008;190: 923-928.
50. Jacobs PCA, Isgum I, Gondrie MJA, Mali WPTM, Ginneken B, Prokop M, Graaf Y: Coronary artery calcification scoring in low-dose ungated CT screening for lung cancer: Interscan agreement. AJR Am J Roentgenol 2010;194:1244-1249.
51. Moscariello A, Vliegenthart R, Schoepf UJ, Nance JW, Zwerner PL, Meyer M, Townsend JC, Fernandes V, Sieinber DH, Fink C, Oudkerk M, Bonoma L, O'Brien TX, Henzler T: Coronary CT angiography versus conventional cardiac angiography for therapeutic decision making in patients with high likelihood of coronary artery disease. Radiology 2012;265:385-392.
52. Boudina S, Abel ED: Diabetic cardiomyopathy revisited. Circulation 2007;115:3213-3223.
53. Ernande L, Rietzschel ER, Bergerot C, Wen H: Impaired myocardial radial function in asymptomatic patients with type 2 diabetes mellitus: A speckle-tracking imaging study. J Am Soc Echocardiogr 2010;23:1266-1272.
54. Ernande L, Thibault H, Bergerot C, Moulin P, Wen H, Derumeaux G, Croisille P: Systolic myocardial dysfunction in patients with type 2 diabetes mellitus: Identification at MR imaging with cine displacement encoding with stimulated echoes. Radiology 2012;265:402-409.
55. Giovannucci E, Harlan DM, Archer MC, Bergenstal RM, Gapstur SM, Habel LA, Pollack M, Regensteiner JG, Yee D: Diabetes and cancer. A consensus report. Diabetes Care 2010;33:1674-1685.
56. Pickhardt PJ, Hassan C, Laqhi A, Zullo A, Kim DH, Iafrate F, Morini S: Small and diminutive polyps detected at screening CT colonography: A decision analysis for referral to colonoscopy. AJR Am J Roentgenol 2002;190:136-144.
57. Austin JA, Garg K, Aberle D, Yankelevitz D, Kuriyama K, Lee HJ, Brambilla E, Travis WD: Radiologic implications of the 2011 classification of adenocarcinoma of the lung. Radiology 2013;266:62-71.
58. Travis WD, Garg K, Franklin WA, Wistuba II, Sabloff B, Noguch M, Kakinuma R, Zakowski M, Ginsberg M, Padera R, Jacobson F, Johnson B: Evolving concepts in the pathol- ogy and computed tomography imaging of lung adenocarcinoma and bronchioloalveolar carcinoma. J Clin Oncol 2005;23:3279-3287.
59. Lee HY, Li Z, Chen K, Hsu AR, Xu C, Sun S, Chen X: PET/ MRI dual-modality tumor imaging using arginine-glycineaspartic (RGD)-conjugated radiolabeled iron oxide nanoparticles. J Nucl Med 2008;49:1371-1379.
60. Xie J, Chen K, Huang J, Lee S, Wang J, Gao J, Li X, Chen X: PET/NIRF/MRI triple functional iron oxide nanoparticles. Biomaterial 2010;31:3016-3022.
61. Krokowski M: Progressive theory of carcinogenesis suggesting that frequency of metastatic dissemination is related to tumor size. In: Kaiser WA, ed. MR-Mammography. Berlin: Springer-Verlag, 1993:3-22.
62. Ouwerkerk R, Pettigrew RI, Gharib AM: Liver metabolite concentrations measured with 1H MR spectroscopy. Radiology 2012;265:565-575.
63. Antkowiak PF, Vandsburger MH, Epstein FH: Quantitative pancreatic beta cell MRI using manganese-enhanced Look- Locker imaging and two-site water exchange analysis. Magn Reson Med 2012;67:1730-1739.
64. Marc D, Normandin MD, Petersen KF, Ding YS, Lin SF, Naik S, Fowles K, Skovronsky DM, Herold KC, McCarthy TJ, Calle RA, Carson RE, Treadway JL, Cline GW: In vivo imaging of endogenous pancreatic b-cell mass in healthy and type 1 diabetic subjects using 18F-fluoropropyldihydrotetrabenazine and PET. J Nucl Med 2012;53:908-916.
65. Labbé, SM, Grenier-Larouche T, Noll C, Phoenix S, Gue'rin B, Turcotte EE, Carpentier AA: Increased myocardial uptake of dietary fatty acids linked to cardiac dysfunction in glucoseintolerant humans. Diabetes 2012;61:2701-2710.